Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells.

Metz-Zumaran, Camila; Kee, Carmon; Doldan, Patricio; Guo, Cuncai; Stanifer, Megan L; Boulant, Steeve

Metz-Zumaran, Camila; Kee, Carmon; Doldan, Patricio; Guo, Cuncai; Stanifer, Megan L; Boulant, Steeve.

Afiliação

Metz-Zumaran C; Department of Infectious Diseases, Virology, Heidelberg University, Heidelberg, Germany.
Kee C; Department of Infectious Diseases, Virology, Heidelberg University, Heidelberg, Germany.
Doldan P; Research Group "Cellular Polarity and Viral Infection," German Cancer Research Center (DKFZ), Heidelberg, Germany.
Guo C; Department of Infectious Diseases, Virology, Heidelberg University, Heidelberg, Germany.
Stanifer ML; Research Group "Cellular Polarity and Viral Infection," German Cancer Research Center (DKFZ), Heidelberg, Germany.
Boulant S; Department of Infectious Diseases, Virology, Heidelberg University, Heidelberg, Germany.

J Virol ; 96(7): e0170521, 2022 04 13.

Article em En | MEDLINE | ID: mdl-35262371

Assuntos

Tratamento Farmacológico da COVID-19; Interferon Tipo I; Interferons; SARS-CoV-2; Antivirais/farmacologia; Antivirais/uso terapêutico; Células Cultivadas; Células Epiteliais; Humanos; Interferon Tipo I/farmacologia; Interferons/farmacologia; SARS-CoV-2/efeitos dos fármacos; Interferon lambda

Palavras-chave

SARS-CoV-2; human intestinal epithelial cells; interferon; interferon lambda; intrinsic immune response; type III interferon

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interferon Tipo I / Interferons / SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google